Skip to main content

Zohydro ER FDA Approval History

FDA Approved: Yes (Discontinued) (First approved October 25, 2013)
Brand name: Zohydro ER
Generic name: hydrocodone
Dosage form: Extended-Release Capsules
Company: Zogenix, Inc.
Treatment for: Pain

Zohydro ER (hydrocodone) is a single-entity (without acetaminophen) extended-release opioid analgesic for around-the-clock management of moderate to severe chronic pain.

Development timeline for Zohydro ER

DateArticle
Jan 30, 2015Approval Zogenix Receives FDA Approval for New Abuse-Deterrent Formulation of Zohydro ER
Oct 25, 2013Approval FDA Approves Zohydro ER, an Extended-Release, Single-Entity Hydrocodone Product
Feb 27, 2013Zogenix Provides Update on Zohydro ER Regulatory Review
Dec 10, 2012Zogenix Provides Update on FDA Advisory Committee Meeting for Zohydro ER for Management of Chronic Pain
Nov 16, 2012Zogenix Announces FDA Advisory Committee Review of Zohydro ER for the Management of Chronic Pain
Jul 16, 2012Zogenix Announces U.S. Food and Drug Administration (FDA) Acceptance for Review of Zohydro ER New Drug Application (NDA) for Treatment of Chronic Pain
May  2, 2012Zogenix Submits New Drug Application (NDA) to U.S. Food and Drug Administration (FDA) for Zohydro for Treatment of Chronic Pain

See also

Zohydro ER (hydrocodone) Consumer information

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Medical Disclaimer